Funding for this research was provided by:
National Institute on Aging (1R01AG048678-01A1, 1R01AG059689-01A1, 1R01NS089932-01A1)
Chan Zuckerberg Initiative Collaborate Science Award (2018-191983)
BrightFocus Foundation (A2019060)
Chan Zuckerberg Initiative Collaborative Science Award (2018-191983)
Article History
Received: 17 October 2020
Revised: 23 March 2021
Accepted: 24 March 2021
First Online: 8 April 2021
Declarations
:
: One of the authors (MID) is a co-inventor of an anti-tau therapeutic antibody (ABBV-8E12) that is in clinical trials.